Comparative Pharmacology
Head-to-head clinical analysis: AMINOACETIC ACID 1 5 IN PLASTIC CONTAINER versus RESECTISOL IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AMINOACETIC ACID 1 5 IN PLASTIC CONTAINER versus RESECTISOL IN PLASTIC CONTAINER.
AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER vs RESECTISOL IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Aminoacetic acid (glycine) acts as an inhibitory neurotransmitter in the central nervous system and is involved in various metabolic processes. As a 1.5% solution in plastic container, it provides free amino acid for parenteral nutrition, contributing to protein synthesis and maintenance of nitrogen balance.
RESECTISOL (mannitol) is an osmotic diuretic that increases osmotic pressure of glomerular filtrate, thereby inhibiting tubular reabsorption of water and electrolytes, leading to increased urine output. It also reduces intracranial pressure and cerebral edema by creating an osmotic gradient that draws water from brain tissue into plasma.
Intravenous infusion of 1.5% aminoacetic acid solution. Typical adult dose: 500 mL to 1000 mL infused over 2 to 4 hours as needed, based on clinical response and electrolyte balance.
36 mg/mL acetic acid solution instilled into the renal pelvis via nephrostomy catheter; single dose of 60-240 mL depending on stone burden, retained for 10-15 minutes, then aspirated. May be repeated weekly up to 3 doses.
None Documented
None Documented
1-2 hours; prolonged in renal impairment (up to 8-10 hours if GFR <30 mL/min).
Terminal half-life: 1.5–2 hours (predominantly determined by redistribution; prolonged in hepatic impairment).
Renal: >95% unchanged; tubular reabsorption is minimal. Biliary/fecal: <5%.
Renal: ~50-60% as unchanged drug and metabolites; biliary/fecal: ~35-40% (mainly metabolites).
Category C
Category C
Irrigating Solution
Irrigating Solution